In Silico Prediction of Cytochrome P450-Drug Interaction: QSARs for CYP3A4 and CYP2C9

Cytochromes P450 (CYP) are the main actors in the oxidation of xenobiotics and play a crucial role in drug safety, persistence, bioactivation, and drug-drug/food-drug interaction. This work aims to develop Quantitative Structure-Activity Relationship (QSAR) models to predict the drug interaction with two of the most important CYP isoforms, namely 2C9 and 3A4. The presented models are calibrated on 9122 drug-like compounds, using three different modelling approaches and two types of molecular description (classical molecular descriptors and binary fingerprints). For each isoform, three classification models are presented, based on a different approach and with different advantages: (1) a very simple and interpretable classification tree; (2) a local (k-Nearest Neighbor) model based classical descriptors and; (3) a model based on a recently proposed local classifier (N-Nearest Neighbor) on binary fingerprints. The salient features of the work are (1) the thorough model validation and the applicability domain assessment; (2) the descriptor interpretation, which highlighted the crucial aspects of P450-drug interaction; and (3) the consensus aggregation of models, which largely increased the prediction accuracy.

[1]  S. Hirono,et al.  Simple Method of Calculating Octanol/Water Partition Coefficient. , 1992 .

[2]  Roberto Todeschini,et al.  Reshaped Sequential Replacement for variable selection in QSPR: comparison with other reference methods , 2014 .

[3]  Roberto Todeschini,et al.  Investigating the mechanisms of bioconcentration through QSAR classification trees. , 2016, Environment international.

[4]  Roberto Todeschini,et al.  N3 and BNN: Two New Similarity Based Classification Methods in Comparison with Other Classifiers , 2015, J. Chem. Inf. Model..

[5]  A. Karlin,et al.  Electrostatic potential of the acetylcholine binding sites in the nicotinic receptor probed by reactions of binding-site cysteines with charged methanethiosulfonates. , 1994, Biochemistry.

[6]  C. Hansch,et al.  Quantitative structure-activity relationships of cytochrome P-450. , 1993, Drug metabolism reviews.

[7]  Ruili Huang,et al.  Comprehensive Characterization of Cytochrome P450 Isozyme Selectivity across Chemical Libraries , 2009, Nature Biotechnology.

[8]  Sean Ekins,et al.  KOHONEN MAPS FOR PREDICTION OF BINDING TO HUMAN CYTOCHROME P450 3A4 , 2004, Drug Metabolism and Disposition.

[9]  A. Munro,et al.  What makes a P450 tick? , 2013, Trends in biochemical sciences.

[10]  G. Caldwell,et al.  Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery. , 2001, Current topics in medicinal chemistry.

[11]  M. Schwab,et al.  Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. , 2013, Pharmacology & therapeutics.

[12]  F. Guengerich,et al.  Role of cytochrome P450 enzymes in drug-drug interactions. , 1997, Advances in pharmacology.

[13]  Pengyu Y. Ren,et al.  Calculation of protein–ligand binding free energy by using a polarizable potential , 2008, Proceedings of the National Academy of Sciences.

[14]  M. Clifford,et al.  Quantitative structure activity relationship for the effect of benzoic acids, cinnamic acids and benzaldehydes on Listeria monocytogenes. , 1996, The Journal of applied bacteriology.

[15]  Yongjun Wang,et al.  Considerations and recent advances in QSAR models for cytochrome P450-mediated drug metabolism prediction , 2008, J. Comput. Aided Mol. Des..

[16]  Roberto Todeschini,et al.  Comparison of Different Approaches to Define the Applicability Domain of QSAR Models , 2012, Molecules.

[17]  J. Bridges,et al.  The role of substrate lipophilicity in determining type 1 microsomal P450 binding characteristics. , 1978, Biochemical pharmacology.

[18]  P. Watkins Role of Cytochromes P45O in Drug Metabolism and Hepatotoxicity , 1990, Seminars in liver disease.

[19]  Michael C. Brown An Adverse Interaction between Warfarin and 5-Fluorouracil: A Case Report and Review of the Literature , 1999, Chemotherapy.

[20]  Mark A. Murcko,et al.  Virtual screening : an overview , 1998 .

[21]  D. Butina,et al.  Performance of Kier-Hall E-state descriptors in quantitative structure activity relationship (QSAR) studies of multifunctional molecules. , 2004, Molecules.

[22]  Ola Spjuth,et al.  WhichCyp: prediction of cytochromes P450 inhibition , 2013, Bioinform..

[23]  G. McLachlan Discriminant Analysis and Statistical Pattern Recognition , 1992 .

[24]  Yu Zong Chen,et al.  Prediction of Cytochrome P450 3A4, 2D6, and 2C9 Inhibitors and Substrates by Using Support Vector Machines , 2005, J. Chem. Inf. Model..

[25]  Leo Breiman,et al.  Classification and Regression Trees , 1984 .

[26]  BioChem Press,et al.  QSPR with TAU Indices: Water Solubility of Diverse Functional Acyclic Compounds # , 2003 .

[27]  Roberto Todeschini,et al.  Defining a novel k-nearest neighbours approach to assess the applicability domain of a QSAR model for reliable predictions , 2013, Journal of Cheminformatics.

[28]  Risto O. Juvonen,et al.  Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes , 2015, Front. Pharmacol..

[29]  F. Gonzalez,et al.  Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. , 1994, Drug metabolism reviews.

[30]  Francesca Grisoni,et al.  Variable selection methods : an introduction , 2012 .

[31]  R. Leardi,et al.  Genetic algorithms applied to feature selection in PLS regression: how and when to use them , 1998 .

[32]  D A Smith,et al.  Design of drugs involving the concepts and theories of drug metabolism and pharmacokinetics , 1996, Medicinal research reviews.

[33]  C. Beedham The role of non—P450 enzymes in drug oxidation. , 1997, Pharmacy World and Science.

[34]  T. R. Brodribb,et al.  Phenytoin and Fluorouracil Interaction , 2001, The Annals of pharmacotherapy.

[35]  Roberto Todeschini,et al.  Molecular descriptors for chemoinformatics , 2009 .

[36]  E. Frei,et al.  The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts. , 2001, Biochemical pharmacology.

[37]  B. Kowalski,et al.  K-Nearest Neighbor Classification Rule (pattern recognition) applied to nuclear magnetic resonance spectral interpretation , 1972 .

[38]  Ian T. Jolliffe,et al.  Principal Component Analysis , 2002, International Encyclopedia of Statistical Science.

[39]  Khadija Iqbal,et al.  An introduction , 1996, Neurobiology of Aging.

[40]  R. Geary,et al.  The Contiguity Ratio and Statistical Mapping , 1954 .

[41]  R. Venkataraghavan,et al.  Atom pairs as molecular features in structure-activity studies: definition and applications , 1985, J. Chem. Inf. Comput. Sci..

[42]  Ruili Huang,et al.  CERAPP: Collaborative Estrogen Receptor Activity Prediction Project , 2016, Environmental health perspectives.

[43]  F. Gonzalez,et al.  Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. , 2005, Mutation research.

[44]  W. Pryor Cytochrome P450: Structure, mechanism, and biochemistry , 1996 .

[45]  Anthony Long,et al.  Computer systems for the prediction of xenobiotic metabolism. , 2002, Advanced drug delivery reviews.

[46]  F. Guengerich Mechanisms of cytochrome P450 substrate oxidation: MiniReview , 2007, Journal of biochemical and molecular toxicology.

[47]  Ernst Mutschler,et al.  Drug actions : basic principles and theraputic aspects , 1995 .

[48]  H. Mei,et al.  An improved large-scale prediction model of CYP1A2 inhibitors by using combined fragment descriptors , 2015 .

[49]  David Rogers,et al.  Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..

[50]  S. Wold,et al.  Partial least squares analysis with cross‐validation for the two‐class problem: A Monte Carlo study , 1987 .

[51]  M Cassotti,et al.  Validation and extension of a similarity-based approach for prediction of acute aquatic toxicity towards Daphnia magna , 2014, SAR and QSAR in environmental research.

[52]  Berith F. Jensen,et al.  In silico prediction of cytochrome P450 2D6 and 3A4 inhibition using Gaussian kernel weighted k-nearest neighbor and extended connectivity fingerprints, including structural fragment analysis of inhibitors versus noninhibitors. , 2007, Journal of medicinal chemistry.

[53]  Stewart B Kirton,et al.  Comparative modelling of cytochromes P450. , 2002, Advanced drug delivery reviews.

[54]  Heng Tao Shen,et al.  Principal Component Analysis , 2009, Encyclopedia of Biometrics.

[55]  David E. Goldberg,et al.  Genetic algorithms and Machine Learning , 1988, Machine Learning.

[56]  Ram Vinay Pandey,et al.  Novel advances in cytochrome P450 research. , 2011, Drug discovery today.

[57]  Sason Shaik,et al.  Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes. , 2004, Chemical reviews.

[58]  Ruili Huang,et al.  Predictive Models for Cytochrome P450 Isozymes Based on Quantitative High Throughput Screening Data , 2011, J. Chem. Inf. Model..

[59]  Maurizio Vichi,et al.  Studies in Classification Data Analysis and knowledge Organization , 2011 .

[60]  Thorsten Meinl,et al.  KNIME: The Konstanz Information Miner , 2007, GfKl.

[61]  U. Yasar,et al.  Inhibitory effect of 5-fluorouracil on cytochrome P450 2C9 activity in cancer patients. , 2006, Basic & clinical pharmacology & toxicology.

[62]  Maurice Dickins,et al.  Compound lipophilicity for substrate binding to human P450s in drug metabolism. , 2004, Drug discovery today.

[63]  Roberto Todeschini,et al.  New Spectral Indices for Molecule Description , 2008 .

[64]  Ruili Huang,et al.  ehp CERAPP : Collaborative Estrogen Receptor Activity Prediction Project , 2016 .

[65]  Emilio Benfenati,et al.  Integration of QSAR models for bioconcentration suitable for REACH. , 2013, The Science of the total environment.

[66]  Theofanis Sapatinas,et al.  Discriminant Analysis and Statistical Pattern Recognition , 2005 .

[67]  S Udenfriend,et al.  Hydroxylation-induced migration: the NIH shift. Recent experiments reveal an unexpected and general result of enzymatic hydroxylation of aromatic compounds. , 1967, Science.